申请人:Endocyte, Inc.
公开号:US20150314015A1
公开(公告)日:2015-11-05
Described herein are compositions, methods, compounds, conjugates, and kits for use in targeted drug delivery using drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations, such as inflammatory cells.
本文描述了用于靶向药物传递的组合物、方法、化合物、共轭物和试剂盒,其中包含亲水性空间连接剂的药物传递共轭物,用于治疗由病原细胞群引起的疾病状态,例如炎症细胞。